NS Pharma, Inc.
Denise Barrett Quigley is a seasoned marketing professional with extensive experience in the pharmaceutical and healthcare sectors. Currently serving as the Marketing Director at NS Pharma, Inc., Denise has played a pivotal role in building brand strategies and executing the launch plan for Viltepso. Previous roles include impactful positions at Pfizer, Otsuka Pharmaceutical Companies, CSL Behring, and Merck & Co. Denise has a strong background in payer marketing, strategic planning, and commercial leadership, with a proven track record of successfully launching and positioning products across various therapeutic markets. Educational credentials include a Master of Public Administration in Healthcare Policy and Administration from Rutgers University, an MBA in Marketing from Sacred Heart University, and a BA in English and Philosophy from the University of Connecticut.
This person is not in the org chart
This person is not in any offices
NS Pharma, Inc.
2 followers
NS Pharma, Inc. (NSP) located in Paramus New Jersey is a subsidiary of Nippon Shinyaku Co., Ltd. Founded in 1999 in the United States, NSP is engaged in clinical studies and partnering with global pharmaceutical companies, venture companies and research institutes. NSP serves as a contact point for connecting Japan/Asia and the world, developing drug candidates invented in Japan and out-license them to the world. From the world to Japan/Asia, NSP in-license promising drug candidates to the Japanese/Asian Markets. In coordination with parent company, Nippon Shinyaku, Co., Ltd., NSP will first and foremost develop and supply safe and highly effective pharmaceuticals through clinical studies. NSP aims to be an indispensable entity in the healthcare industry in line with the guidelines for action “Challenge”, “Speed”, and “Investigation”.